The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.

The FDA has set back Aldeyra Therapeutics’ ambitions to win approval for its dry eye disease, rejecting its second ...

Aldeyra Therapeutics shares fell 73% to $1.42 in the regular session after it reported a Food and Drug Administration complete response letter for reproxalap for treatment of dry eye disease. The ...

It’s a mad, mad, mad world out there, folks.Legislators are mad about drug companies and pharmacy benefit managers (PBMs) ...

Medically reviewed by Christine L. Larsen, MD Dry eyes can feel gritty, scratchy, or burning and can cause blurred vision, ...

The topical ocular drug is an investigational new drug candidate that requires more well-controlled studies to establish ...

Treatments for dry eye disease include lifestyle changes, over-the-counter treatments, prescription medications, and in-office procedures. Over-the-counter artificial tears, gels, and ointments ...

If you see a doctor, you may also get a prescription medication encouraging tears. Your doctor might suggest targeting the ...

2 "With VEVYE Access for All, we are disrupting the status quo in U.S. prescription dry eye access," said Mark ... patients from benefitting from medications they are prescribed.

Key findings indicated that a 20% increase in market share of TearCare compared to prescription dry eye medications would yield an estimated annual savings of $36.87 per member per year across all ...